[go: up one dir, main page]

MX9704024A - Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1. - Google Patents

Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1.

Info

Publication number
MX9704024A
MX9704024A MX9704024A MX9704024A MX9704024A MX 9704024 A MX9704024 A MX 9704024A MX 9704024 A MX9704024 A MX 9704024A MX 9704024 A MX9704024 A MX 9704024A MX 9704024 A MX9704024 A MX 9704024A
Authority
MX
Mexico
Prior art keywords
hiv
reverse transcriptase
infection
prevention
treatment
Prior art date
Application number
MX9704024A
Other languages
English (en)
Other versions
MXPA97004024A (es
Inventor
Jan Maria Rene Balzarini
Original Assignee
Rega Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rega Inst filed Critical Rega Inst
Publication of MXPA97004024A publication Critical patent/MXPA97004024A/es
Publication of MX9704024A publication Critical patent/MX9704024A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion y método para la prevencion o el tratamiento de infeccion por VIH-1, la cual comprende un compuesto de carb(ox/tio)anilida heterociclílica inhibidor de transcriptasa inversa de VIH-1, un segundo compuesto inhibidor de transcriptasa inversa de VIH-1 que no selecciona para la misma cepa o cepas mutantes de VIH-1 seleccionadas por el compuesto de carb(ox/tio)anilida heterociclílica, y opcionalmente un tercer compuesto inhibidor de transcriptasa inversa de VIH.
MX9704024A 1994-11-30 1995-11-29 Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1. MX9704024A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US346721 1994-11-30
US08/346,721 US5968910A (en) 1994-11-30 1994-11-30 Compositions containing two or three inhibitors of different HIV reverse transcriptases
PCT/EP1995/004704 WO1996016675A2 (en) 1994-11-30 1995-11-29 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
MXPA97004024A MXPA97004024A (es) 1998-02-01
MX9704024A true MX9704024A (es) 1998-02-28

Family

ID=23360750

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704024A MX9704024A (es) 1994-11-30 1995-11-29 Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1.

Country Status (16)

Country Link
US (1) US5968910A (es)
EP (1) EP0794793B1 (es)
JP (1) JP3655636B2 (es)
KR (1) KR100403545B1 (es)
CN (1) CN1104909C (es)
AU (1) AU717025B2 (es)
BR (1) BR9509925A (es)
CA (1) CA2204652C (es)
DE (1) DE69535366T2 (es)
HU (1) HU223548B1 (es)
IL (1) IL115944A (es)
MX (1) MX9704024A (es)
NZ (1) NZ297006A (es)
RU (1) RU2227750C2 (es)
WO (1) WO1996016675A2 (es)
ZA (1) ZA9510108B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696151A (en) * 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
JP2001512830A (ja) * 1997-08-08 2001-08-28 ニューバイオティックス インコーポレイテッド 生物療法耐性および化学療法耐性を克服するための方法および組成物
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6245750B1 (en) 1998-01-23 2001-06-12 Newbiotics, Inc. Enzyme catalyzed therapeutic agents
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
WO2001021160A2 (en) * 1999-09-23 2001-03-29 Axxima Pharmaceuticals Aktiengesellschaft Carboxymide and aniline derivatives as selective inhibitors of pathogens
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
CN101108178B (zh) * 2006-07-20 2010-09-15 复旦大学 一种亲环素a抑制剂在制备抗艾滋病药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5268389A (en) * 1989-10-16 1993-12-07 Uniroyal Chemical Company, Inc. Thiocarboxylate ester compounds compositions containing the same
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
DE69120069T2 (de) * 1991-09-04 1996-10-02 Consejo Superior Investigacion Substituierte Nukleosidderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
JPH10500996A (ja) 1998-01-27
BR9509925A (pt) 1997-09-30
DE69535366T2 (de) 2007-10-11
RU2227750C2 (ru) 2004-04-27
WO1996016675A3 (en) 1996-08-29
NZ297006A (en) 2001-03-30
IL115944A (en) 2001-10-31
US5968910A (en) 1999-10-19
WO1996016675A2 (en) 1996-06-06
KR987000088A (ko) 1998-03-30
HU223548B1 (hu) 2004-09-28
CN1104909C (zh) 2003-04-09
HUT77573A (hu) 1998-06-29
IL115944A0 (en) 1996-05-14
JP3655636B2 (ja) 2005-06-02
EP0794793A1 (en) 1997-09-17
KR100403545B1 (ko) 2004-05-27
AU717025B2 (en) 2000-03-16
CA2204652A1 (en) 1996-06-06
DE69535366D1 (de) 2007-02-22
CA2204652C (en) 2009-04-07
AU4176996A (en) 1996-06-19
EP0794793B1 (en) 2007-01-10
ZA9510108B (en) 1996-06-06
CN1167442A (zh) 1997-12-10

Similar Documents

Publication Publication Date Title
ES2114487B1 (es) Mezcla estabilizante sinergistica.
FI20085256A7 (fi) Retrovirusperäisten proteaasi-inhibiittoreiden yhdistelmä
BR9307011A (pt) Membro de vedação
SE9604793D0 (sv) New polymorphs
LV12719A (lv) Benzoxazinones as inhibitors of hiv reverse transcriptase
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
NO305478B1 (no) Hydroksyetylaminosulfonamider som retrovirale proteasehemmere
AU688952B2 (en) Thrombin inhibitors
AU5242000A (en) Nematicidal trifluorobutenes
ATE209191T1 (de) Parazinon thrombin inhibitoren
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
ES2131185T3 (es) Arilalcanil-n-hidroxiureas y heteroalquilalcanil-n-hidroxiureas sustituidas que pueden inhibir la biosintesis de leucotrienos.
AP9200410A0 (en) Retroviral protease inhibitors.
AU8074894A (en) Hiv protease inhibitors and intermediates
CA2154572A1 (fr) Application du riluzole dans le traitement du neuro-sida
MX9704024A (es) Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1.
ATE157988T1 (de) Neuartige prolyl-endopeptidase-inhibitoren sna- 115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
ZA991029B (en) Composition and methods for treatment of hiv infections.
EE9700165A (et) Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks
IL132477A0 (en) Methods of screening compounds useful for prevention of infection or pathogenicity
AU6739396A (en) Method for combatting fish mycoses and one-celled ectoparasites
MX9603898A (es) Bioensayo para inhibidores de transcriptasa inversa.
MY140504A (en) Statin-mmp inhibitor combinations
EP0355409A3 (en) Use of prolylendopeptidase inhibitors in the treatment of aids